Report copyright - Oriol Puig Sant Josep 2015 Hospital de Bellvitge joint IAEA, EANM, and SNMMI oractical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. J. J. Zaknum
Please pass captcha verification before submit form